Atrophy Clinical Trial
Official title:
Effects of Exercise on Multiple Risk Factors and Health Costs in Community Living Elderly Women. The Senior Fitness and Prevention Study (SEFIP)
The purpose of this study is to determine whether exercise training may impact relevant risk factors and health costs of community living women older 65 years.
The human aging process is associated with a significant increase of risk factors (i.e.
osteoporosis, coronary heard disease, diabetes) and a decline in neuromuscular function
impacting independence of the subject. Osteoporosis, diabetes type II and arteriosclerosis
are diseases known to correlate with age. Participating in regular sport activities elicits
numerous favorable effects that contribute to "healthy aging". Unfortunately all existing
studies which focus on specific diseases or conditions favour dedicated exercise regimes.
However, the complex risk factor scenario of older adults requires multi-purpose exercise
programs with impact on all relevant risks. Furthermore so far no exercise study
longitudinally determines the effect of an ambulatory exercise program on health cost
considering the specific health policy framework of Germany. We hypothesize that regular
exercise
1. significantly impact relevant osteoporosis, cardiovascular diseases and diabetes risk
factors in elderly subjects
2. significantly reduces health costs in elderly community living women
;
Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02781623 -
Quantifying Quadriceps Atrophy Following Tibial Plateau Fracture
|
||
Completed |
NCT02497547 -
An Efficacy Study of Vagitocin in Postmenopausal Women With Symptoms of Vaginal Atrophy
|
Phase 2 | |
Completed |
NCT02332343 -
Sparing of the Fovea in Geographic Atrophy Progression
|
N/A | |
Completed |
NCT00566982 -
A Clinical Study to Evaluate the Safety of Ospemifene
|
Phase 3 | |
Completed |
NCT01586364 -
Long-Term Safety of Ospemifene 60 mg Oral Daily Dose for the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women Without a Uterus
|
Phase 3 | |
Active, not recruiting |
NCT05698316 -
A Collaborative Resource of Heidelberg Multimodal Imaging of Intermediate and Early Atrophic AMD Cases to Study Prediction of Disease Progression
|
||
Recruiting |
NCT05869812 -
Influence of β-hydroxy β-methyl Butyrate (HMB)Supplementation on Post-operative Muscle Mass and Function in Female Athletes
|
Phase 2 | |
Completed |
NCT02747641 -
Prospective, Open-Label, Single-Center, Non-Comparative Study to Assess the Use of Pixel CO2 Laser System (FemiLift) in the Treatment of Vulvovaginal Atrophy (VVA) in Postmenopausal Female Subjects
|
N/A | |
Completed |
NCT02770365 -
Comparative Safety and Efficacy of Two Treatments in the Treatment of Vulvar and Vaginal Atrophy
|
Phase 3 | |
Recruiting |
NCT02137824 -
A Modified Sinus Floor Elevation Technique - a Pilot Study on 12 Patients
|
N/A | |
Completed |
NCT01585558 -
Long-Term Safety of 30 mg and 60 mg Oral Daily Dose of Ospemifene in the Treatment of Vulvar and Vaginal Atrophy (VVA) in Postmenopausal Women With Intact Uterus
|
Phase 3 | |
Completed |
NCT02868749 -
Histology and Ultrasound Pilot Study of HA Gels Adipose Tissue
|
N/A | |
Recruiting |
NCT01911312 -
Evaluation of Thermal-Aided Muscle Stimulation
|
N/A | |
Completed |
NCT00729469 -
Efficacy and Safety of Ospemifene in the Treatment of Moderate to Severe Vaginal Dryness and Vaginal Pain Associated With Sexual Activity
|
Phase 3 | |
Completed |
NCT01553773 -
Postmenopausal Facial Skin After Estradiol and Genistein Topical Treatment
|
Phase 2 | |
Recruiting |
NCT02745366 -
Buccal Fat Pad Derived Stem Cells With Cortical Tenting in Posterior Mandible Reconstruction
|
Phase 1 | |
Completed |
NCT00744094 -
Resistance Training in Elderly
|
Phase 1/Phase 2 | |
Completed |
NCT00807508 -
Leucine Supplementation in Elderly Men
|
Phase 1/Phase 2 | |
Completed |
NCT00276094 -
A Clinical Study to Evaluate Ospemifene in the Treatment of Vulvar and Vaginal Atrophy in Postmenopausal Women
|
Phase 3 | |
Terminated |
NCT00292916 -
Effect of Whole Body Vibration on Bone and Fall Related Parameters
|
Phase 3 |